A research paper on AI-driven drug discovery by SAKURA internet and COGNANO was accepted by NeurIPS 2024, a prestigious AI conference

KYOTO, Japan -- A joint research paper on artificial intelligence (AI)-driven drug discovery by “SAKURA internet Research Center,” an in-house research institute of SAKURA internet Inc., and COGNANO, Inc. (hereinafter referred to as “COGNANO”), has been accepted for the Datasets and Benchmarks Track at the Neural Information Processing Systems (NeurIPS) 2024, one of the most prestigious international conferences in the field of AI and machine learning. Read More

A research paper on AI-driven drug discovery by SAKURA internet and COGNANO was accepted by NeurIPS 2024, a prestigious AI conference

A research paper on AI-driven drug discovery by SAKURA internet and COGNANO was accepted by NeurIPS 2024, a prestigious AI conference

A research paper on AI-driven drug discovery by SAKURA internet and COGNANO was accepted by NeurIPS 2024, a prestigious AI conference

A research paper on AI-driven drug discovery by SAKURA internet and COGNANO was accepted by NeurIPS 2024, a prestigious AI conference
A research paper on AI-driven drug discovery by SAKURA internet and COGNANO was accepted by NeurIPS 2024, a prestigious AI conference
Ads Links by Easy Branches
Play online games for free at games.easybranches.com
Guest Post Services www.easybranches.com/contribute
Sable Identifies Cu-bearing Magmatic Hydrothermal Breccias at its Copper Queen Project in British Columbia

DirecTV will buy rival Dish to create massive pay-TV company after yearslong pursuit